Skip to main navigation Skip to search Skip to main content

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single Dose of Exebacase in Adult Patients Receiving Standard of Care Antibiotics for the Treatment of Staphylococcus aureus Bloodstream Infections . . .

Project: Research

Project Details

StatusFinished
Effective start/end date11/19/20 → 11/18/22

Funding

  • ContraFect Corporation: $36,335.00